Celltrion reaches milestone on COVID-19 super antibody

Smart people are smart. Fast techniques are fast. Smart people with fast techniques is what you are looking for in situations like the one COVID-19 set us in.

Seo [Jung-Jin, Celltrion Chairman] said Celltrion has completed what it considers the “most difficult part” of the process, the construction of a 300-antibody library from blood samples collected from recovered patients.

According to Seo, Celltrion aims to develop a super antibody that will be able to “perfectly adapt to any mutations.” When asked how, he explained: “There is an average lag time of three months between the mutation and the production of a product that has adapted to the mutation. And we will adapt the product to the mutation within those three months.”

Also Celltrion

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: